Vistagen Therapeutics (VTGN) Net Income (2009 - 2026)
Vistagen Therapeutics' Net Income came in at -$10.74 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$19.42 million a year earlier.
Vistagen Therapeutics (VTGN) Net Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Vistagen Therapeutics reported Net Income of -$58.94 million; for FY2026 (ended Mar 31, 2026), it came in at -$69.69 million.
- Going back by fiscal year, Net Income was -$51.42 million in FY2025, -$29.36 million in FY2024, -$59.25 million in FY2023 and -$47.76 million in FY2022.
- The fiscal Q2 2027 figure represents the highest quarterly Net Income since fiscal Q1 2025.
- Business Quant data shows VTGN's Net Income at -$13.03 million (Q1 2027), -$16.27 million (Q4 2026) and -$18.9 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -1.95 Mn |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 6.45 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 210.00 Mn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 4.22 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 5.07 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - | -10.74 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -10.74 Mn |
| Jun 30, 2026 | -13.03 Mn |
| Mar 31, 2026 | -16.27 Mn |
| Dec 31, 2025 | -18.90 Mn |
| Sep 30, 2025 | -19.42 Mn |
| Jun 30, 2025 | -15.10 Mn |
| Mar 31, 2025 | -13.64 Mn |
| Dec 31, 2024 | -14.09 Mn |
| Sep 30, 2024 | -12.96 Mn |
| Jun 30, 2024 | -10.73 Mn |
| Mar 31, 2024 | -9.52 Mn |
| Dec 31, 2023 | -6.35 Mn |
| Sep 30, 2023 | -6.59 Mn |
| Jun 30, 2023 | -6.90 Mn |
| Mar 31, 2023 | -12.23 Mn |
| Dec 31, 2022 | -9.76 Mn |
| Sep 30, 2022 | -17.48 Mn |
| Jun 30, 2022 | -19.78 Mn |
| Mar 31, 2022 | -16.69 Mn |
| Dec 31, 2021 | -10.53 Mn |
Vistagen Therapeutics Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();